Related Experiment Videos
Stem cell transplantation in the fetus.
Marcus O Muench1, Alicia Bárcena
1Department of Laboratory Medicine, University of California, San Francisco, CA 94143, USA. muench@itsa.ucsf.edu
Cancer Control : Journal of the Moffitt Cancer Center
|March 17, 2004
Summary
In utero transplantation (IUT) shows promise for treating blood disorders by replacing hematopoietic stem cells. Current research focuses on overcoming engraftment barriers for broader clinical application.
Area of Science:
- Reproductive Medicine
- Hematology
- Immunology
Background:
- In utero transplantation (IUT) offers potential for treating numerous hematologic and metabolic diseases.
- Partial replacement of the hematopoietic system is the primary goal of IUT.
Purpose of the Study:
- To review clinical and experimental experiences with IUT.
- To examine the development of hematopoietic and immune systems in the context of IUT.
Main Methods:
- Literature review focusing on IUT.
- Analysis of clinical and experimental data on IUT outcomes.
- Evaluation of hematopoietic and immune system development post-IUT.
Main Results:
- IUT has shown success primarily in treating immunodeficiencies affecting lymphocyte development.
- Clinically significant engraftment has not been achieved for conditions like thalassemias.
- Strategies to overcome engraftment barriers include donor cell advantages and immune tolerance induction.
- Animal models are evaluating cellular components (T cells, dendritic cells) and combined transplantation for improved engraftment.
Conclusions:
- The benefits of early treatment encourage further development of IUT.
- IUT is a promising approach for treating hematopoietic and other birth defects.
- Continued research is essential to enhance IUT efficacy and expand its applications.